diabetic ketoacidosis

Euglycaemic diabetic ketoacidosis as a severe complication of dapagliflozin

01 maart 2022

Abstract Diabetic ketoacidosis (DKA) is a severe and potentially lethal complication of diabetes. The use of a relatively new class of antihyperglycaemic drugs, the SGLT2 inhibitors, can cause DKA, albeit with a different presentation compared to the ‘classic’ DKA. Therefore, since it might not be recognised at an early stage,…